Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Simone

Showing results (191-200 of 370) with videos related to

Pageof 37
Sort By:
European Urology|July 20, 2025
Single-port Antegrade Robotic Lymphadenectomy: A Novel Minimally Invasive Approach to Treat Lymph Nodes in Men with Penile CancerAldo Brassetti, Alfredo Maria Bove, Flavia Proietti, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Radiomic Machine-Learning Analysis of Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: New Combination of Textural and Clinical FeaturesFrancesco Prata, Umberto Anceschi, Ermanno Cordelli, et al.
The Prostate|August 4, 2022
Serum levels of chromogranin are not predictive of poorly differentiated prostate cancer: Results from a multicenter radical prostatectomy cohortRiccardo Lombardo, Lorenzo Rovesti, Antonio Cicione, et al.
Sensors (Basel, Switzerland)|September 9, 2023
Robotic Medtronic Hugo™ RAS System Is Now Reality: Introduction to a New Simulation Platform for Training ResidentsLoris Cacciatore, Manuela Costantini, Francesco Tedesco, et al.
European Urology Focus|September 9, 2020
Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free SurvivalRiccardo Mastroianni, Ado Brassetti, Wojciech Krajewski, et al.
World Journal of Urology|December 12, 2022
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracyRomain Diamand, Alexandre Peltier, Jean-Baptiste Roche, et al.
Prostate Cancer and Prostatic Diseases|December 2, 2022
The impact of locoregional treatments for metastatic castration resistant prostate cancer on disease progression: real life experience from a multicenter cohortMariaconsiglia Ferriero, Francesco Prata, Riccardo Mastroianni, et al.
Journal of Personalized Medicine|September 28, 2023
Robot-Assisted Renal Surgery with the New Hugo Ras System: Trocar Placement and Docking SettingsFrancesco Prata, Gianluigi Raso, Alberto Ragusa, et al.
European Urology Focus|October 9, 2022
Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?Romain Diamand, Simone Albisinni, Jean-Baptiste Roche, et al.
World Journal of Urology|October 13, 2019
Managing lines of therapy in castration-resistant prostate cancer: real-life snapshot from a multicenter cohortMariaconsiglia Ferriero, Riccardo Mastroianni, Cosimo De Nunzio, et al.
Pageof 37

Showing results (191-200 of 370) with videos related to

Sort By:
Pageof 37
European Urology|July 20, 2025
Single-port Antegrade Robotic Lymphadenectomy: A Novel Minimally Invasive Approach to Treat Lymph Nodes in Men with Penile CancerAldo Brassetti, Alfredo Maria Bove, Flavia Proietti, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Radiomic Machine-Learning Analysis of Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: New Combination of Textural and Clinical FeaturesFrancesco Prata, Umberto Anceschi, Ermanno Cordelli, et al.
The Prostate|August 4, 2022
Serum levels of chromogranin are not predictive of poorly differentiated prostate cancer: Results from a multicenter radical prostatectomy cohortRiccardo Lombardo, Lorenzo Rovesti, Antonio Cicione, et al.
Sensors (Basel, Switzerland)|September 9, 2023
Robotic Medtronic Hugo™ RAS System Is Now Reality: Introduction to a New Simulation Platform for Training ResidentsLoris Cacciatore, Manuela Costantini, Francesco Tedesco, et al.
European Urology Focus|September 9, 2020
Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free SurvivalRiccardo Mastroianni, Ado Brassetti, Wojciech Krajewski, et al.
World Journal of Urology|December 12, 2022
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracyRomain Diamand, Alexandre Peltier, Jean-Baptiste Roche, et al.
Prostate Cancer and Prostatic Diseases|December 2, 2022
The impact of locoregional treatments for metastatic castration resistant prostate cancer on disease progression: real life experience from a multicenter cohortMariaconsiglia Ferriero, Francesco Prata, Riccardo Mastroianni, et al.
Journal of Personalized Medicine|September 28, 2023
Robot-Assisted Renal Surgery with the New Hugo Ras System: Trocar Placement and Docking SettingsFrancesco Prata, Gianluigi Raso, Alberto Ragusa, et al.
European Urology Focus|October 9, 2022
Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?Romain Diamand, Simone Albisinni, Jean-Baptiste Roche, et al.
World Journal of Urology|October 13, 2019
Managing lines of therapy in castration-resistant prostate cancer: real-life snapshot from a multicenter cohortMariaconsiglia Ferriero, Riccardo Mastroianni, Cosimo De Nunzio, et al.
Pageof 37